Here, we identify the mSWI/SNF complex as a therapeutic vulnerability in other TF-driven malignancies, namely POU2F3-driven SCLC and POU2AF1-dependent B cell malignancies. The gene discussed is POU2F3; the disease is small cell lung carcinoma.